| 383 | For use in combination with moisturizers or oral antihistamines in patients with atopic dermatitis who have failed or are intolerant to an 8 week trial of an intermediate potency topical steroid. |
| | Therapy should be reassessed at 6 months. |
| | LU Authorization Period: 1 year |
